Agenus (AGEN) to Release Quarterly Earnings on Thursday


Share on StockTwits

Agenus (NASDAQ:AGEN) will be issuing its quarterly earnings data before the market opens on Thursday, May 6th. Analysts expect the company to announce earnings of ($0.31) per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link.

Agenus (NASDAQ:AGEN) last released its quarterly earnings data on Sunday, March 14th. The biotechnology company reported ($0.20) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.22) by $0.02. The company had revenue of $31.27 million for the quarter, compared to the consensus estimate of $16.23 million. On average, analysts expect Agenus to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Shares of Agenus stock opened at $3.05 on Tuesday. The firm has a 50-day moving average of $2.92 and a 200-day moving average of $3.55. The stock has a market cap of $624.29 million, a PE ratio of -2.80 and a beta of 1.86. Agenus has a 52-week low of $2.28 and a 52-week high of $5.95.

A number of brokerages have recently issued reports on AGEN. B. Riley reissued a “buy” rating and issued a $8.00 target price on shares of Agenus in a research report on Friday, January 15th. Zacks Investment Research downgraded Agenus from a “hold” rating to a “sell” rating in a research note on Tuesday, April 27th.

About Agenus

Agenus Inc, a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies.

Recommended Story: Do stock splits help investors?

Earnings History for Agenus (NASDAQ:AGEN)

Receive News & Ratings for Agenus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agenus and related companies with MarketBeat.com's FREE daily email newsletter.